510(k) device
Mesh Nebulizer (H6)
Qingdao Future Medical Technology Co., Ltd. · Nebulizer (Direct Patient Interface) (CAF, Class II) · First FDA decision Nov 14, 2025, newest Nov 14, 2025AsthmaCOPD and emphysema
Last checked: Nov 19, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
1
510(k) pathway
Device trials
160
Naming "Nebulizer"
MAUDE reports
1,304
Brand "Nebulizer", since 2015
PubMed studies
4,416
Mentioning "Nebulizer"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing Mesh Nebulizer (H6)
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 1 of 1 decisions filed under this name.
- Mesh Nebulizer (H6)510(k)
K251659 · Decided Nov 14, 2025 · 168 days after receipt
Device type: Nebulizer (Direct Patient Interface) (CAF) · Anesthesiology & Respiratory
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
- NebulizersLocal determinationIn effectL33370CGS Administrators, LLCUpdated Feb 12, 2026
- NebulizersProposed local determinationProposedDL33370CGS Administrators, LLCUpdated Aug 22, 2025
Clinical trials
Device studies on ClinicalTrials.gov that name "Nebulizer", any status and sponsor, newest update first.
- A Phase 2 Study of LTI-03 in Patients With Idiopathic Pulmonary FibrosisPivotal-lookingRecruiting
Rein TherapeuticsNot on our public-company list
NCT06968845 · 120 participants (planned) · Start Feb 2, 2026 · Primary completion Sep 30, 2027
Device: Dry Powder Inhaler · For: Idiopathic Pulmonary Fibrosis (IPF)
Sites: Birmingham, Alabama; Los Angeles, California; San Diego, California · 48 sites in all
- Pharyngeal Mucosal Conditioning to Prevent Postoperative Sore Throat in Septoplasty Patients With Severe Nasal ObstructionPivotal-lookingRecruiting
Mansoura UniversityAcademic, hospital or other
NCT07870252 · 105 participants (planned) · Start Oct 15, 2026 · Primary completion Apr 15, 2027
Device: Nebulized 0.9% Normal Saline; Water-Soluble Lubricant Gel on Endotracheal Tube and 1 more · For: Postoperative Sore Throat; Nasal Obstruction; Septoplasty
Sites: Buraidah, Saudi Arabia
- Comparison of Bronchodilator Response From Three Different Aerosol Delivery Methods in Patients With COPD Using Hyperpolarized Xe 129 MRI Ventilation ImagingActive, not recruiting
Polarean, Inc.Not on our public-company list
NCT06271408 · 6 participants (planned) · Start Mar 19, 2024 · Primary completion Dec 31, 2026
Device: Vibrating Mesh Nebulizer; Metered Dose Inhaler and 1 more · For: Chronic Obstructive Pulmonary Disease
Sites: Charlottesville, Virginia
157 more trials with a free account
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "Nebulizer", and for the whole product code for context.
This brand
1,304 reports: 1,203 malfunction, 71 injury, 5 death
Whole product code CAF
2,410 reports: 2,117 malfunction, 199 injury, 27 death
Newest reports for this brand
1417592-2026-10941 · Received Oct 29, 2026 · Event dated Aug 15, 2026
Device type: Tubing, Pressure And Accessories (BYX)
Device problem as coded: Contamination /Decontamination Problem; Packaging Problem
Patient problem as coded: Bacterial Infection; Pneumonia
MW6004542 · Received Oct 26, 2026
Device type: Nebulizer (Direct Patient Interface) (CAF)
Device problem as coded: Fluid/Blood Leak
Patient problem as coded: No Clinical Signs, Symptoms or Conditions
1417592-2026-10907 · Received Oct 26, 2026 · Event dated Aug 15, 2026
Device type: Tubing, Pressure And Accessories (BYX)
Device problem as coded: Contamination /Decontamination Problem; Packaging Problem
Patient problem as coded: Bacterial Infection; Pneumonia
2 more reports with a free account
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
No recall in FDA's data is linked to these FDA numbers.
Published research
The most relevant PubMed records for "Nebulizer"[tiab]. The summary above synthesizes these.
- Assessing nebulizer performance.
Dolovich MB · Respir Care · 2002Review
- Nebulizer decontamination.
Allan J, Cunniffe JG, Edwards C, et al. · J Hosp Infect · 2005Letter
- Nebulizer-induced anisocoria.
Lust K, Livingstone I · Ann Intern Med · 1998Case Reports, Letter
- Effect of therapeutic play using a toy nebulizer and toy mask on a child's fear and anxiety levels.
Krkan Ç, Kahraman A · J Pediatr Nurs · 2023Randomized Controlled Trial
- Nebulizer function.
Massey DG, Miyauchi D, Fournier-Massey G · Bull Eur Physiopathol Respir · 1982Research Support, Non-U.S. Gov't
- Basic nebulizer function.
Nerbrink O, Dahlbäck M · J Aerosol Med · 1994
- Home nebulizer service.
McIntyre P, Attfield L, Humpherson C, et al. · Respir Med · 1995Letter
- Measuring nebulizer output.
Beach JR · Chest · 1998Comment, Letter
- Nebulizer contamination.
Alexander GD, Crowley TP · Anesth Analg · 1978Letter
- Nebulizer function during mechanical ventilation.
O'Riordan TG, Greco MJ, Perry RJ, et al. · Am Rev Respir Dis · 1992Comparative Study, Research Support, U.S. Gov't, P.H.S.
- Brand-name market exclusivity for nebulizer therapy to treat asthma and COPD.
Feldman WB, Bloomfield D, Beall RF, et al. · Nat Biotechnol · 2022Research Support, Non-U.S. Gov't, Research Support, N.I.H., Extramural
- Nebulizer Use by Black and Latinx Adults with Moderate to Severe Asthma.
Apter A, Carroll JK, Cardet JC, et al. · J Allergy Clin Immunol Pract · 2022Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't
Other devices of this type
Also filed under product code CAF.
- Propeller Sensor for SymbicortReciprocal Labs Corporation · 510(k) 2020
- Hailie Sensor NF0110Adherium (Nz), Ltd. · 510(k) 2023
- eRapid with eTrack SystemPari Respiratory Equipment, Inc. · 510(k) 2025
- Ultrasonic Mesh NebulizerFoshan Gaunying Electronics Co., Ltd. · 510(k) 2014
- Portable NebulizerMicrobase Technology Corporation · 510(k) 2018
- SmartTouchAdherium (Nz), Ltd. · 510(k) 2018
- Comp A-I-ROmron Healthcare, Inc. · 510(k) 2014
- Ultrasonic Nebulizer (Mesh Type)K-Jump Health Co., Ltd. · 510(k) 2013
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.